Dobbelstein, Matthias

[["dc.bibliographiccitation.firstpage","1836"],["dc.bibliographiccitation.issue","9"],["dc.bibliographiccitation.journal","Aging"],["dc.bibliographiccitation.lastpage","1837"],["dc.bibliographiccitation.volume","8"],["dc.contributor.author","Sriraman, Anusha"],["dc.contributor.author","Li, Yizhu"],["dc.contributor.author","Dobbelstein, Matthias"],["dc.date.accessioned","2018-11-07T10:08:52Z"],["dc.date.available","2018-11-07T10:08:52Z"],["dc.date.issued","2016"],["dc.identifier.doi","10.18632/aging.101073"],["dc.identifier.isi","000390311600004"],["dc.identifier.pmid","27688014"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/39555"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Impact Journals Llc"],["dc.relation.issn","1945-4589"],["dc.title","Fortifying p53-beyond Mdm2 inhibitors"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dc.type.subtype","letter_note"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","45"],["dc.bibliographiccitation.journal","Cancer Letters"],["dc.bibliographiccitation.lastpage","54"],["dc.bibliographiccitation.volume","428"],["dc.contributor.author","Li, Yizhu"],["dc.contributor.author","Köpper, Frederik"],["dc.contributor.author","Dobbelstein, Matthias"],["dc.date.accessioned","2020-12-10T14:22:49Z"],["dc.date.available","2020-12-10T14:22:49Z"],["dc.date.issued","2018"],["dc.identifier.doi","10.1016/j.canlet.2018.04.030"],["dc.identifier.issn","0304-3835"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/71747"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-354"],["dc.title","Inhibition of MAPKAPK2/MK2 facilitates DNA replication upon cancer cell treatment with gemcitabine but not cisplatin"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]